Response to Park et al. reply to 'Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study'.
Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Belfast, UK.
Seán O
0000-0002-3092-7945
SO
Hynes
Centre for Public Health, Queen's University Belfast, Belfast, UK.
Helen G
HG
Coleman
Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Belfast, UK.|Department of Tissue Pathology, Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, UK.
Paul J
PJ
Kelly
Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Belfast, UK.
Philip D
PD
Dunne
Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Belfast, UK.|Department of Tissue Pathology, Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, UK.
Manuel
M
Salto-Tellez
Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Belfast, UK.|Department of Tissue Pathology, Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, UK.
Maurice B
MB
Loughrey
D003110:Colonic Neoplasms; D006801:Humans; D009367:Neoplasm Staging; D011379:Prognosis; D012107:Research Design; D059016:Tumor Microenvironment